» Articles » PMID: 23863764

Phosphodiesterase 4D Single-nucleotide Polymorphism 83 and Cognitive Dysfunction in Carotid Endarterectomy Patients

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 2013 Jul 19
PMID 23863764
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phosphodiesterase 4D (PDE4D), through the regulation of cyclic AMP, modulates inflammation and other processes that affect atherosclerosis and stroke. A PDE4D polymorphism, single-nucleotide polymorphism (SNP) 83 (rs966221), is associated with ischemic stroke. The association of SNP 83 with postoperative cognitive dysfunction has never been investigated.

Objective: To determine whether SNP 83 is associated with cognitive dysfunction 1 day and 1 month following carotid endarterectomy (CEA).

Methods: Three hundred fourteen patients with high-grade carotid stenosis scheduled for CEA consented to participate in this single-center cohort study of cognitive dysfunction.

Results: Patients with the C/C genotype of SNP 83 exhibited significantly more cognitive dysfunction at 1 day (29.7%) than the C/T (15.8%, P = .008) and T/T (12.7%, P = .01) genotypes. In a multivariate logistic regression model, C/T and T/T genotypes were both associated with significantly decreased odds of cognitive dysfunction compared with the C/C genotype (odds ratio, 0.45 [0.24-0.83], P = .01 and odds ratio, 0.33 [0.12-0.77], P = .02). There were no significant associations at 1 month.

Conclusion: The C/C genotype of SNP 83 is significantly associated with the highest incidence of cognitive dysfunction 1 day following CEA in comparison with the C/T and T/T genotypes. This PDE4D genotype may lead to accelerated cyclic AMP degradation and subsequently elevated inflammation 1 day after CEA. These observations, in conjunction with previous studies, suggest that elevated inflammatory states may be partially responsible for the development of cognitive dysfunction after CEA, but more investigation is required.

Citing Articles

Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.

Schenning K, Holden S, Davis B, Mulford A, Nevonen K, Quinn J J Alzheimers Dis. 2021; 83(3):1251-1268.

PMID: 34420963 PMC: 8801332. DOI: 10.3233/JAD-210499.


Cognitive Reserve and the Risk of Postoperative Cognitive Dysfunction.

Feinkohl I, Winterer G, Spies C, Pischon T Dtsch Arztebl Int. 2017; 114(7):110-117.

PMID: 28302254 PMC: 5359463. DOI: 10.3238/arztebl.2017.0110.


No Association Between Single-Nucleotide Polymorphism 56 (SNP56) in Phosphodiesterase 4D (PDE4D) Gene and Susceptibility to Ischemic Stroke: A Meta-Analysis of 15 Studies.

Zhang X, Wan Q, Zhu D Med Sci Monit. 2016; 22:3820-3827.

PMID: 27759733 PMC: 5083063. DOI: 10.12659/MSM.896904.

References
1.
Moller J, Cluitmans P, Rasmussen L, Houx P, Rasmussen H, Canet J . Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998; 351(9106):857-61. DOI: 10.1016/s0140-6736(97)07382-0. View

2.
Woo D, Kaushal R, Kissela B, Sekar P, Wolujewicz M, Pal P . Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke. 2005; 37(2):371-6. DOI: 10.1161/01.STR.0000198843.72824.0a. View

3.
Rasmussen L . Postoperative cognitive dysfunction: incidence and prevention. Best Pract Res Clin Anaesthesiol. 2006; 20(2):315-30. DOI: 10.1016/j.bpa.2005.10.011. View

4.
Gigante P, Kotchetkov I, Kellner C, Haque R, Ducruet A, Hwang B . Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy. J Neurol Neurosurg Psychiatry. 2010; 82(3):247-53. PMC: 3245519. DOI: 10.1136/jnnp.2010.211144. View

5.
Banner K, Trevethick M . PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease. Trends Pharmacol Sci. 2004; 25(8):430-6. DOI: 10.1016/j.tips.2004.06.008. View